LISTEN LIVE: Loading...

Advertisement

 

As omicron surges, two new drugs approved to treat COVID-19 patients

06:31
Download
Play
This article is more than 1 year old.

As cases COVID-19 surge around the country, driven by the omicron variant, there's some good news too. Two new treatments have been approved by the Food and Drug Administration — both of them pills shown to reduce serious illness, hospitalization and death among high-risk patients.

So what's the difference between Merck's Molnupiravir and Pfizer's Paxlovid? And what other treatments are available as we head into the third year of the pandemic?

Here & Now's Celeste Headlee checks in with virologist Angela Rasmussen at the University of Saskatchewan.

This segment aired on December 23, 2021.

Advertisement

 
Play
Listen Live
/00:00
Close